drugset / Trial / NCT02185326

Microflare Protocol in Poor Responders

NCT02185326

Phase 4 Completed 145 enrolled Woman's Health University Hospital, Egypt
RandomizedParallel-groupOpen-labelTreatment

Summary

The effect of use of the microflare down regulation protocol on the outcome of the IVF/ICSI cycles in poor responders

Timeline

Start
2014-07
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Somatropin Protein / enzyme biologic 2.5 mg Subcutaneous

Indications